Related Experiment Video

Updated: Aug 30, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management

Margaret Rosenfeld1, Bonnie W Ramsey, Ronald L Gibson

  • 1Department of Pediatrics, University of Washington, Seattle, USA.

Current Opinion in Pulmonary Medicine
|October 10, 2003
PubMed

Insights

Early Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) patients presents a window for intervention. However, aggressive treatment offers only transient eradication, with re-infection being common.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Genetics

Background:

  • Chronic Pseudomonas aeruginosa (Pa) infection significantly increases morbidity and mortality in cystic fibrosis (CF) patients.
  • Early Pa acquisition does not immediately precipitate rapid lung function decline.
  • Early Pa isolates are typically non-mucoid, antibiotic-sensitive, and present in low concentrations.

Purpose of the Study:

  • To review the pathophysiology, risk factors, and outcomes of early Pa infection in CF.
  • To summarize findings from early intervention trials.
  • To outline current treatment strategies for early Pa infection.

Main Methods:

  • Literature review of studies on early Pseudomonas aeruginosa infection in cystic fibrosis.
  • Analysis of clinical trial data for early intervention strategies.
  • Synthesis of information on pathophysiology, risk factors, and treatment outcomes.

Main Results:

  • Early Pa infection in CF patients offers a potential window for intervention due to sensitive bacterial characteristics.
  • Anti-pseudomonal therapy achieves temporary eradication but does not prevent eventual re-infection.
  • Current evidence lacks controlled trials demonstrating clear clinical benefits of early intervention in young children.

Conclusions:

  • While early intervention can transiently clear Pseudomonas aeruginosa, re-infection is a significant challenge in cystic fibrosis care.
  • Further research is essential to determine the long-term clinical benefits and optimal treatment regimens for early Pa infections.
  • Investigating the long-term safety and efficacy of various drug protocols is critical for improving outcomes in CF patients.
Abstract

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...